ENANTA PHARMACEUTICALS INC

SEC 10-K Item 1C disclosure describing the registrant's general cybersecurity risk management and strategy program (NIST framework, vISO, IRP, penetration testing, phishing simulations, cyber insurance, Audit Committee oversight). The filing affirmatively states the environment contains no known risks from cybersecurity threats that could materially impact operations, financials, or reputation. No specific cybersecurity incident is disclosed.